Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

Urban-rural disparity in cervical cancer in China and feasible interventions for tackling the rural excess.

Wen X, Wen D, Yang Y, Chen Y, Akazawa K, Liu Y, Shan B.

Medicine (Baltimore). 2019 Jan;98(1):e13907. doi: 10.1097/MD.0000000000013907.

2.

Methylation of p16 ink4a promoter is independent of human papillomavirus DNA physical state: a comparison between cervical pre-neoplastic and neoplastic samples.

Carestiato FN, Amaro-Filho SM, Moreira MAM, Cavalcanti SMB.

Mem Inst Oswaldo Cruz. 2018 Dec 17;114:e180456. doi: 10.1590/0074-02760180456.

3.

[Evaluation of 114 abnormal Pap smear follow-up in ambulatory care.]

Peccatte É, Vallée J, Trombert B, Savall A.

Sante Publique. 2018 July August;30(4):527-532. doi: 10.3917/spub.185.0527. French.

PMID:
30540142
4.

Why Do Women Get Cervical Cancer in an Organized Screening Program in Canada?

Jackson R, Wang L, Jembere N, Murphy J, Kupets R.

J Low Genit Tract Dis. 2019 Jan;23(1):1-6. doi: 10.1097/LGT.0000000000000450.

PMID:
30489433
5.

Utilization of Pap testing among women living with HIV enrolled in primary care in Baltimore, Maryland: A 10-year longitudinal study, 2005-2014.

Peprah S, Coleman JS, Rositch AF, Vanden Bussche CJ, Moore R, D'Souza G.

Papillomavirus Res. 2018 Dec;6:52-57. doi: 10.1016/j.pvr.2018.10.002. Epub 2018 Oct 25.

6.

Neo-adjuvant treatment of adenocarcinoma and squamous cell carcinoma of the cervix results in significantly different pathological complete response rates.

Couvreur K, Naert E, De Jaeghere E, Tummers P, Makar A, De Visschere P, Van Bockstal M, Van Dorpe J, De Neve W, Denys H, Vandecasteele K.

BMC Cancer. 2018 Nov 12;18(1):1101. doi: 10.1186/s12885-018-5007-0.

7.

Overall survival and time trends in breast and cervical cancer incidence and mortality in the Regional Health District (RHD) of Barretos, São Paulo, Brazil.

da Costa AM, Hashim D, Fregnani JHTG, Weiderpass E.

BMC Cancer. 2018 Nov 7;18(1):1079. doi: 10.1186/s12885-018-4956-7.

8.

Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014.

Ojamaa K, Innos K, Baburin A, Everaus H, Veerus P.

BMC Cancer. 2018 Nov 7;18(1):1075. doi: 10.1186/s12885-018-5006-1.

9.

Single type infection of human papillomavirus as a cause for high-grade cervical intraepithelial neoplasia and invasive cancer in Japan.

Sakamoto J, Kamiura S, Okayama K, Okodo M, Shibata T, Osaka Y, Fujita S, Takata E, Takagi H, Takakura M, Sasagawa T.

Papillomavirus Res. 2018 Dec;6:46-51. doi: 10.1016/j.pvr.2018.10.001. Epub 2018 Oct 26.

10.

HPV Vaccination of Girl Child in India: Intervention for Primary Prevention of Cervical Cancer

Roy S, Shankar A.

Asian Pac J Cancer Prev. 2018 Sep 27;19(9):2357-2358.

11.

Anxiety and Depression in Thai Women with Abnormal Cervical Cytology who Attended Colposcopic Unit in Thammasat University Hospital

Phuakpoolpol S, Suwannarurk K, Jaisin K, Punyashthira A, Pattaraarchachai J, Bhamarapravatana K.

Asian Pac J Cancer Prev. 2018 Oct 26;19(10):2985-2989.

12.

High Prevalence of Human Papillomavirus Types 56 and 70 Identified in the Native Populations of Sabah, Malaysia

Sainei NE, Kumar VS, Chin YS, Salih FAM.

Asian Pac J Cancer Prev. 2018 Oct 26;19(10):2807-2813.

13.

HPV16-Related Cervical Cancers and Precancers Have Increased Levels of Host Cell DNA Methylation in Women Living with HIV.

Kremer WW, van Zummeren M, Heideman DAM, Lissenberg-Witte BI, Snijders PJF, Steenbergen RDM, Dreyer G, Meijer CJLM.

Int J Mol Sci. 2018 Oct 23;19(11). pii: E3297. doi: 10.3390/ijms19113297.

14.

Clearance and persistence of the human papillomavirus infection among Cameroonian women.

Akaaboune M, Kenfack B, Viviano M, Temogne L, Catarino R, Tincho E, Mbobda J, Tran PL, Camail R, Vassilakos P, Petignat P.

Womens Health (Lond). 2018 Jan-Dec;14:1745506518805642. doi: 10.1177/1745506518805642.

15.

Human papillomavirus genotyping among women with cervical abnormalities in Ulaanbaatar, Mongolia.

Tsedenbal B, Yoshida T, Enkhbat B, Gotov U, Sharkhuu E, Saio M, Fukuda T.

Int J Infect Dis. 2018 Dec;77:8-13. doi: 10.1016/j.ijid.2018.09.018. Epub 2018 Sep 24.

16.

Diagnostic performance of the E6/E7 mRNA-based Optimygene HR-HPV RT-qDx assay for cervical cancer screening.

Wang HY, Kim H, Park KH.

Int J Infect Dis. 2019 Jan;78:22-30. doi: 10.1016/j.ijid.2018.09.014. Epub 2018 Sep 21.

17.

Cervical cancer prevention: An Italian scenario between organised screening and human papillomaviruses vaccination.

Cappelli MG, Fortunato F, Tafuri S, Boccalini S, Bonanni P, Prato R, Martinelli D.

Eur J Cancer Care (Engl). 2018 Sep;27(5):e12905. doi: 10.1111/ecc.12905. Epub 2018 Sep 4.

18.

Association between a national quality improvement program and excisional treatment of cervical dysplasia in Australia.

Foster L, Robson SJ.

J Obstet Gynaecol Res. 2018 Nov;44(11):2085-2090. doi: 10.1111/jog.13767. Epub 2018 Aug 23.

PMID:
30141245
19.

Reliability of colposcopy during pregnancy.

Ciavattini A, Serri M, Di Giuseppe J, Liverani CA, Fallani MG, Tsiroglou D, Papiccio M, Delli Carpini G, Pieralli A, Clemente N, Sopracordevole F.

Eur J Obstet Gynecol Reprod Biol. 2018 Oct;229:76-81. doi: 10.1016/j.ejogrb.2018.07.029. Epub 2018 Jul 27.

PMID:
30118992
20.

MRI measurement of residual cervical length after radical trachelectomy for cervical cancer and the risk of adverse pregnancy outcomes: a blinded imaging analysis.

Alvarez RM, Biliatis I, Rockall A, Papadakou E, Sohaib SA, deSouza NM, Butler J, Nobbenhuis M, Barton D, Shepherd JH, Ind T.

BJOG. 2018 Dec;125(13):1726-1733. doi: 10.1111/1471-0528.15429. Epub 2018 Sep 17.

PMID:
30099822

Supplemental Content

Loading ...
Support Center